S 5969 requires all substance use disorder treatment facilities to post a "treatment bill of rights" in visible locations and provide a copy to every patient at admission. This bill of rights outlines 10 specific patient rights, including the right to participate in treatment planning, receive clear explanations of services, maintain privacy, and report grievances. It directly affects patients receiving treatment and facility staff, who must also receive copies of the document. The law mandates these postings and distributions without altering existing treatment standards, focusing solely on transparency and patient awareness.
Prohibits the use of restraints on and the use of force against incarcerated individuals during labor and incarcerated individuals who have experienced different pregnancy outcomes, absent extraordinary circumstances, and on pregnant and post-pregnancy persons during a custodial interrogation; provides for certain exceptions for restraints to be used and in such case limits the use to wrist restraints.
Regulates the use of artificial intelligence in the provision of therapy or psychotherapy services by prohibiting the use of artificial intelligence to assist in providing supplementary support where the session is recorded or transcribed unless the patient is informed of the specific purpose of such use and consents of such use; establishes penalties for violations of such provisions; excludes religious counseling, peer-support, and self-help materials and educational resources from such provisions.
Authorizes the commissioner of the office of mental health, and the office of addiction services and support to jointly establish a single set of licensing standards and requirements for the construction, operation, reporting and surveillance of integrated behavioral health services.
Relates to establishing the "340B prescription drug anti-discrimination act"; prohibits pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on participation in the drug discount program authorized by section 340B of the federal public health service act.
Provides for reciprocity agreements with other states for medical cannabis programs; directs the cannabis control board to promulgate regulations for the approval of pre-roll products in the medical cannabis program.
Requires a pharmacy benefit manager to pay a participating pharmacy at minimum at the national average drug acquisition cost (NADAC) rate, or at the pharmacy acquisition cost rate if greater or there is not a NADAC rate, plus a professional dispensing fee that is at minimum the professional dispensing fee paid under the state medical assistance program.
This bill changes the timeframe for adoptive parents to cover certain birth-related expenses for the birth mother. It extends the period from 60 days before birth and 30 days after birth to 180 days before birth and 45 days after birth. The change directly affects adoptive parents and birth mothers in New York adoption cases, allowing payments for reasonable costs like housing, medical care, or transportation during pregnancy and shortly after birth. The bill maintains existing restrictions, such as prohibiting payments to unauthorized agencies and requiring court approval for exceptions beyond the new timeframes.
Establishes the New York dignity in pregnancy and childbirth act; requires hospitals and other facilities that provide perinatal care to implement an evidence-based implicit bias program for all health care providers involved in the perinatal care of patients within those facilities; requires the department of health to publish reports on maternal morbidity and pregnancy related deaths.
Prohibits the retrospective denial of payment for substance use disorder treatment services if an insured was covered for such services at the time treatment was initiated; requires insurers to notify a treatment provider when an insured has lost coverage based on termination of the insured's employment.
